AdaptHealth Corp. (NASDAQ: AHCO) is a Healthcare company (Medical - Devices) with a market capitalization of $1.0B. The Maz Rating grades it against the other companies in its sector.
AdaptHealth Corp.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $7.53, AdaptHealth Corp. trades at 0.3x sales and 0.8x book value, with an EV/EBITDA of 37.1. Over the last twelve months it generated about $3.1B of revenue and a net loss of $405M. It runs a gross margin of 15.3%, an operating margin of -7.4% and a net margin of -12.9%. It shows return on equity of -28.9%, return on invested capital of -6.0% and a free cash flow yield of 8.0%. On the balance sheet: a debt-to-equity ratio of 1.67 and a current ratio of 1.13. Over the past 52 weeks the share price ranged from $5.21 to $13.43, with a beta of 1.36.
AdaptHealth Corp. does not currently pay a dividend.
12 Wall Street analyst ratings cover the stock: 9 Buy, 2 Hold and 1 Sell, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.